Leukemia Research
Volume 30, Issue 9 , Pages 1079-1083 , September 2006

Mutagenic mechanisms in leukemia and cancer: A new concept: Cytosine lack could be as mutagenic as cytosine deamination

  • T.E. Parry

      Affiliations

    • Honorary Consultant Haematologist South Glamorgan Area Health Authority (Teaching) UK and Honorary Vice President Leukaemia Research Appeal for Wales.
    • Corresponding Author InformationTel.: +44 29 20512338.

Received 20 August 2005 ,Accepted 23 December 2005.

References 

  1. Hagenmeijer A. Cytogenetics and Oncogenetics (Review). Leukemia. 1992;6(Suppl. 14):16–83
  2. Jones PA, Rideout FWM, Jeang-Cheng S, et al. Methylatation mutation and cancer. Bioessays. 1992;14:33–36
  3. van Kranen HJ, de Gruijl FR, de Vries A. Frequent p53 alterations but low incidence of ras mutations in UV-induced skin tumours of hairless mice. Carcinogenesis. 1995;16:1141
  4. Chu TM. The molecular diagnosis of pancreatic carcinoma (Review). J Clin Lab Anal. 1997;11:225–231
  5. Lee EJ, Scheiffer CA, Misawa S, Testa JR. Clinical and cytogenetic features of familial erythroleukaemia. Br J Haematol. 1987;65:313–320
  6. Jackon AL, Loeld LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer (Review). Mutat Res. 2001;477:7–21
  7. Parry TE. The non-random distribution of point mutations in leukemia and myelodysplasia: a possible pointer to their aetiology. Leuk Res. 1997;21:559–574
  8. Denissenko MF, Chen JX, Moon-Shong T, et al. Cytosine methylation determines hotspots of DNA damage in the human p53 gene. Proc Natl Acad Sci USA. 1997;94:3893–3898
  9. Kraemer KH. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci USA. 1997;94:11–14
  10. Brash DE. Sunlight and the onset of skin cancer. Trends Genet. 1997;13:410–414
  11. Peng W, Shaw BR. Accelerated deamination of cytosine residues in UV-irradiated cyclobutane pyrimidine dimer leads to CC→TT transitions. Biochemistry. 1996;35:10172–10187
  12. Barak Y, Cohen-Fix O, Livneh . Deamination of cytosine pyrimidine photodimers in UV-irradiated DNA. J Biol Chem. 1995;270:24174–24179
  13. Schuster H, Schram G. Bestimmang der Biologisch wirksamen Eirheit in der Ribosonucleonsaare das Tobakmosaik virus auf cheischen wege. Zeishcriftfur verer bangschre. 1958;135:697–704
  14. Schuster H. The reaction of nitrous acid with deoxyribonucleic acid. Biochem Biophys Res Commun. 1960;2:320–323
  15. Veilmetter , Schuster H. The base specificity of mutations induced by Nitrous acid phase T2. Biochem Biophys Res Commun. 1960;2:324–325
  16. Kaudewitz F. Production of bacterial mutants with nitrous acid. Nature. 1959;183:1829–1830
  17. Freese E. In:  Taylor JH editors. Molecular mechanisms in mutation chapter in molecular genetics part 1. New York: Academic Press; 1963;p. 226
  18. Freese E. In:  Hollae A editors. Molecular mechanisms in mutation chapter in chemical mutagens principles and methods for their detection. vol. 1:New York: Plenium Press; 1971;p. 31
  19. McGilvery RW, Goldstein GW. Biochemistry a functional approach. third ed.. Philadelphia: Saunders; 1983;p. 64, 65 and 123
  20. Tessman I, Liu SK, Kennedy MA. Mechanisms of SOS mutagenesis of UV-irradiated DNA mostly error free processing of deaminated cvtosine. Proc Natl Acad Sci USA. 1992;89:1159–1163
  21. Rideout WM, Coetze GA, Jones PA. 5-methylcytosine as an endogenous mutager in the human LL receptor and p53 gene. Science. 1990;249:1288–1290
  22. Cooper DN, Youssoufian H . The CpG dinucleotide and human genetic disease. Hum Genet. 1988;78:141–153
  23. You YH, Pfeiffer GP. Similarities in sunlight induced mutational spectra of CpG methylated transgenes and p53 genes in skin cancer point to an important role of 5-methylcytosine residues in solar induce mutagenesis. J Mol Biol. 2001;305:389–399
  24. Parry TE. Nucleotide derangement in the megaloblast nucleus. Nature. 1966;212:148–149
  25. Casperson T, Schultz J. Pentose nucleotides in the cytoplasm of growing tissue. Nature. 1934;143:602
  26. Virschur AC, Vangenin AH, Leen R, et al. Cyclopentonyl sodium inhibits cytidine triphosphate synthelase in paediatric acute non-lymphocytic leukemia: a promising target for chemotherapy. Eur J Cancer. 2000;36:627–635
  27. Parry TE. Eur J Cancer. 2000;37:290;(Response to ref. [26])
  28. Parry TE. Serum uracil levels in acute childhood leukaemia. Br J Haematol. 1978;39:241–248
  29. Parry TE. On the pathogenesis of erythroleukemia. Leuk Res. 2005;29:119–121

PII: S0145-2126(06)00022-1

doi: 10.1016/j.leukres.2005.12.019

Leukemia Research
Volume 30, Issue 9 , Pages 1079-1083 , September 2006

Article Tools

* Image Usage & Resolution